Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) Short Interest Update

Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) was the target of a significant growth in short interest during the month of July. As of July 31st, there was short interest totalling 26,400 shares, a growth of 10.0% from the July 15th total of 24,000 shares. Based on an average daily trading volume, of 10,300 shares, the days-to-cover ratio is currently 2.6 days.

Invesco Nasdaq Biotechnology ETF Price Performance

Shares of NASDAQ IBBQ traded up $0.47 during trading hours on Monday, hitting $24.29. 7,770 shares of the stock were exchanged, compared to its average volume of 15,569. Invesco Nasdaq Biotechnology ETF has a one year low of $18.18 and a one year high of $24.74. The company’s 50 day moving average is $23.31 and its 200 day moving average is $22.37. The firm has a market capitalization of $36.19 million, a P/E ratio of 17.39 and a beta of 0.61.

Invesco Nasdaq Biotechnology ETF Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, June 28th. Stockholders of record on Monday, June 24th were given a $0.0506 dividend. This is an increase from Invesco Nasdaq Biotechnology ETF’s previous quarterly dividend of $0.04. This represents a $0.20 annualized dividend and a dividend yield of 0.83%. The ex-dividend date of this dividend was Monday, June 24th.

Hedge Funds Weigh In On Invesco Nasdaq Biotechnology ETF

Institutional investors have recently made changes to their positions in the business. Eudaimonia Advisors LLC bought a new stake in shares of Invesco Nasdaq Biotechnology ETF in the first quarter valued at approximately $1,568,000. Eudaimonia Partners LLC acquired a new position in Invesco Nasdaq Biotechnology ETF during the 1st quarter valued at $923,000. Finally, Lake Street Advisors Group LLC bought a new stake in Invesco Nasdaq Biotechnology ETF in the 1st quarter valued at $286,000.

About Invesco Nasdaq Biotechnology ETF

The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.